-
Ethos recently announced a partnership with Aflac Incorporated, making Aflac’s supplemental cancer insurance available on Ethos’s fully digital life insurance platform to provide rapid, low-friction access to cash benefits for cancer-related costs.
-
This collaboration highlights how Aflac is using third-party technology distribution to widen reach for its supplemental health products and embed coverage directly into modern digital insurance journeys.
-
We’ll now examine how embedding Aflac’s cancer coverage into Ethos’s digital platform could reshape its investment narrative around product distribution.
Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
To own Aflac, you need to believe its core supplemental insurance franchise can offset pressure from declining Japanese premiums and muted growth expectations. The Ethos partnership supports the near term catalyst of improving US distribution, but does not materially change the biggest risk right now, which is structurally weaker premium trends and earnings growth, particularly in Japan.
Among recent announcements, Q3 2025 results showed revenue of US$4,740 million and net income of US$1,639 million, with basic EPS of US$3.09, rebounding from prior year levels. That recovery gives investors more room to focus on how digital distribution moves like Ethos might incrementally support growth, while still weighing longer term headwinds in Japan.
Yet investors should be aware that Aflac’s guidance for negative premium growth in Japan suggests…
Read the full narrative on Aflac (it’s free!)
Aflac’s narrative projects $18.5 billion revenue and $3.8 billion earnings by 2028. This requires 5.1% yearly revenue growth and a roughly $1.4 billion earnings increase from $2.4 billion today.
Uncover how Aflac’s forecasts yield a $111.08 fair value, in line with its current price.
AFL 1-Year Stock Price Chart
Three fair value estimates from the Simply Wall St Community range from US$98.64 to US$162.10, underscoring how far apart individual views can be. As you compare these with the ongoing drag from declining Japanese premiums, it is worth exploring several perspectives on how Aflac’s core market pressures could influence returns over time.
Explore 3 other fair value estimates on Aflac – why the stock might be worth as much as 47% more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.